Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Kinetix enters research collaboration with Dana-Farber Cancer Institute

Feb. 25, 2000

U. of Texas designs new DNA-cleaving compounds

Feb. 25, 2000

Cytotoxic artemisinin derivatives designed at Hong Kong U. of Science & Technology

Feb. 25, 2000

Immune Response's mbGM-CSF vaccine offers protection against melanoma

Feb. 24, 2000

Merck presents new nonpeptide GnRH antagonists

Feb. 24, 2000

Cantharidin analogues as protein phosphatase inhibitors: use in cancer therapy

Feb. 23, 2000

Cell Pathways presents apoptosis-promoting compounds

Feb. 23, 2000

NCI begins phase II trial of O6-benzylguanine/carmustine as glioma therapy

Feb. 23, 2000

Inhibitors of protein prenyltransferases remain a focus of R&D at Merck

Feb. 22, 2000

SBIR grant awarded to NeoRx for lymphoma radioimmunotherapy research

Feb. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...